Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Citrulline malate is a small molecule compound consisting of the non-essential amino acid L-citrulline and malic acid. It is utilized both as a pharmaceutical agent for the treatment of functional asthenia and as a popular dietary supplement for enhancing athletic performance. Mechanistically, L-citrulline acts as a precursor to L-arginine, which in turn serves as a substrate for nitric oxide synthase, leading to increased nitric oxide production and improved vasodilation. This process enhances blood flow and nutrient delivery to active tissues. Malate, an intermediate in the citric acid cycle, supports aerobic energy production by facilitating ATP synthesis and aiding in the clearance of metabolic waste products such as ammonia and lactate. Originally developed by Biocodex and marketed under the brand name Stimol, citrulline malate is indicated for the symptomatic relief of fatigue and recovery from physical exertion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on citrulline malate.